Simplify Logo

Full-Time

Health Economics & Market Access Manager

Hema, UK & Ireland

Posted on 5/28/2024

iRhythm Technologies

iRhythm Technologies

1,001-5,000 employees

Ambulatory cardiac monitoring with wearable biosensors

Data & Analytics

Mid

Remote in UK

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Communications
Requirements
  • Bachelor’s Degree in Health Economics or Science-related field and/or demonstrable relevant experience
  • Solid experience in UK & Ireland market access of Medical Devices
  • Comprehensive knowledge of funding and reimbursement mechanisms across the UK and Ireland
  • Ability to translate scientific evidence into compelling value argumentations
  • Highly analytical with excellent written and verbal skills
  • Outstanding communication and interpersonal skills
  • Comfortable & motivated by working in a matrix, international organisation
  • Excellent interpersonal skill with the ability to build trusted working relations
  • Creative, willing to try new approaches and think out-of-the-box
  • Fluent in English
  • Ability to travel up to 50% annually
Responsibilities
  • Develop the UK&I market access strategy development
  • Develop & implement comprehensive business cases
  • Collaborate with key functions to co-create the National Value Strategy Plan
  • Anticipate access barriers and evaluate threats and opportunities
  • Lead the development of localised payer engagement tools
  • Construct and own strong relationships with key external payers
  • Gather external stakeholders’ insights through key strategic partnerships
  • Support the International iRhythm business in developing real-world evidence strategy
  • Support the implementation of HEMA tools and materials
  • Ensure full representation and participation of market access function in country commercial team meetings

The Zio service by iRhythm Technologies provides a next-generation ambulatory cardiac monitoring solution with single-use monitors, offering continuous and accurate data for up to 14 days. The technology utilizes wearable biosensors, cloud-based data analytics, and proprietary algorithms to distill data from millions of heartbeats into clinically actionable information.

Company Stage

IPO

Total Funding

$1.2B

Headquarters

San Francisco, California

Founded

2006

Growth & Insights
Headcount

6 month growth

4%

1 year growth

14%

2 year growth

32%
INACTIVE